Diabetes drug Avandia should remain on market, U.S. government advisers recommend

WASHINGTON (CP) - The widely used diabetes drug Avandia should remain on the market, U.S. government health advisers recommended Monday, saying evidence of an increased risk of heart attack doesn't merit removal....More